Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128519689> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W3128519689 abstract "Aim: Alemtuzumab is a lymphodepleting monoclonal antibody utilized in conditioning regimens for allogeneic hematopoietic cell transplantation (HCT). A therapeutic range of 0.15-0.6 µg/mL on the day of transplantation is associated with better HCT outcomes. The purpose of this study was to characterize alemtuzumab population pharmacokinetic/pharmacodynamic (PK/PD) and to propose individualized subcutaneous dosing schemes to achieve this optimal level for pediatric patients. Methods: Alemtuzumab concentration and absolute lymphocyte count (ALC) profiles were obtained from 29 patients with non-malignant disorders undergoing HCT. PK/ PD analyses were performed using non-linear mixed effects modeling. Monte Carlo simulation was conducted to evaluate different improved dosing approaches. Results: A one-compartment model with sequential zero- and first-order absorption adequately described subcutaneously administered alemtuzumab PK. Model fit was significantly improved by including allometrically scaled body weight on clearance (0.080 L/h/70kg) and volume of distribution (17.4 L/70kg). ALC reduction following subcutaneous alemtuzumab was swift. An inhibitory Emax model best characterized the relationship between alemtuzumab concentration and ALC. Emax and EC50 were estimated as 1.18*103/µL and 0.045µg/mL, respectively. The currently used per kg dosing was found to cause uneven alemtuzumab exposure across different age and weight cohorts. Simulations indicated target achieving dose as allometry-based of 18 mg*(weight/70)0.75 or body surface area (BSA)-based of 10 mg/m2, divided over 3 days, with a potential individualized top-up dose; both of which yielded similar results. Conclusion: An allometry- or BSA-based starting dosing regimen in combination with individualized Bayesian PK estimation using concentration feedback is proposed for alemtuzumab precision dosing in children undergoing allogeneic HCT." @default.
- W3128519689 created "2021-02-15" @default.
- W3128519689 creator A5013881333 @default.
- W3128519689 creator A5029451403 @default.
- W3128519689 creator A5040060343 @default.
- W3128519689 creator A5061739010 @default.
- W3128519689 creator A5066994838 @default.
- W3128519689 creator A5085671725 @default.
- W3128519689 creator A5090500677 @default.
- W3128519689 date "2021-02-06" @default.
- W3128519689 modified "2023-09-23" @default.
- W3128519689 title "Model-informed precision dosing for alemtuzumab in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation" @default.
- W3128519689 doi "https://doi.org/10.22541/au.161262840.07547609/v1" @default.
- W3128519689 hasPublicationYear "2021" @default.
- W3128519689 type Work @default.
- W3128519689 sameAs 3128519689 @default.
- W3128519689 citedByCount "0" @default.
- W3128519689 crossrefType "posted-content" @default.
- W3128519689 hasAuthorship W3128519689A5013881333 @default.
- W3128519689 hasAuthorship W3128519689A5029451403 @default.
- W3128519689 hasAuthorship W3128519689A5040060343 @default.
- W3128519689 hasAuthorship W3128519689A5061739010 @default.
- W3128519689 hasAuthorship W3128519689A5066994838 @default.
- W3128519689 hasAuthorship W3128519689A5085671725 @default.
- W3128519689 hasAuthorship W3128519689A5090500677 @default.
- W3128519689 hasBestOaLocation W31285196891 @default.
- W3128519689 hasConcept C112705442 @default.
- W3128519689 hasConcept C126322002 @default.
- W3128519689 hasConcept C2777288759 @default.
- W3128519689 hasConcept C2777408962 @default.
- W3128519689 hasConcept C2778384904 @default.
- W3128519689 hasConcept C2779015954 @default.
- W3128519689 hasConcept C2908647359 @default.
- W3128519689 hasConcept C2911091166 @default.
- W3128519689 hasConcept C71924100 @default.
- W3128519689 hasConcept C98274493 @default.
- W3128519689 hasConcept C99454951 @default.
- W3128519689 hasConceptScore W3128519689C112705442 @default.
- W3128519689 hasConceptScore W3128519689C126322002 @default.
- W3128519689 hasConceptScore W3128519689C2777288759 @default.
- W3128519689 hasConceptScore W3128519689C2777408962 @default.
- W3128519689 hasConceptScore W3128519689C2778384904 @default.
- W3128519689 hasConceptScore W3128519689C2779015954 @default.
- W3128519689 hasConceptScore W3128519689C2908647359 @default.
- W3128519689 hasConceptScore W3128519689C2911091166 @default.
- W3128519689 hasConceptScore W3128519689C71924100 @default.
- W3128519689 hasConceptScore W3128519689C98274493 @default.
- W3128519689 hasConceptScore W3128519689C99454951 @default.
- W3128519689 hasLocation W31285196891 @default.
- W3128519689 hasOpenAccess W3128519689 @default.
- W3128519689 hasPrimaryLocation W31285196891 @default.
- W3128519689 hasRelatedWork W1979701407 @default.
- W3128519689 hasRelatedWork W2004325424 @default.
- W3128519689 hasRelatedWork W2095399542 @default.
- W3128519689 hasRelatedWork W2554510980 @default.
- W3128519689 hasRelatedWork W2618079778 @default.
- W3128519689 hasRelatedWork W2793382697 @default.
- W3128519689 hasRelatedWork W2793520024 @default.
- W3128519689 hasRelatedWork W2888766333 @default.
- W3128519689 hasRelatedWork W2959879306 @default.
- W3128519689 hasRelatedWork W3128519689 @default.
- W3128519689 isParatext "false" @default.
- W3128519689 isRetracted "false" @default.
- W3128519689 magId "3128519689" @default.
- W3128519689 workType "article" @default.